GlycoMimetics Ownership 2024 | Who Owns GlycoMimetics Now?
Institutional Ownership
57.22%
Insider Ownership
3.58%
Retail Ownership
39.20%
Institutional Holders
81.00
GlycoMimetics Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
BVF INC/IL | 14.82% | 0.79% | 9,544,262 | - | - | 28,632,786 | Mar 31, 2024 |
ARTAL GROUP S.A. | 13.34% | 0.66% | 8,589,064 | - | - | 25,767,192 | Mar 31, 2024 |
NEA MANAGEMENT COMPANY, LLC | 5.96% | 0.71% | 3,835,039 | -929,401 | -19.51% | 11,505,117 | Mar 31, 2024 |
OCTAGON CAPITAL ADVISORS LP | 4.66% | 1.08% | 3,000,000 | - | - | 9,000,000 | Mar 31, 2024 |
VANGUARD GROUP INC | 4.29% | 0.00% | 2,761,981 | 340,112 | 14.04% | 8,285,943 | Mar 31, 2024 |
AXA S.A. | 2.47% | 0.01% | 1,587,741 | 443 | 0.03% | 4,763,223 | Mar 31, 2024 |
GOLDMAN SACHS GROUP INC | 1.73% | 0.00% | 1,114,708 | 195,353 | 21.25% | 3,344,124 | Mar 31, 2024 |
MILLENNIUM MANAGEMENT LLC | 1.16% | 0.00% | 746,954 | 708,066 | 1820.78% | 2,240,862 | Mar 31, 2024 |
BLACKROCK INC. | 1.14% | 0.00% | 732,567 | -2,416 | -0.33% | 2,197,701 | Mar 31, 2024 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.86% | 0.00% | 554,594 | 554,594 | 100.00% | 1,663,782 | Mar 31, 2024 |
GEODE CAPITAL MANAGEMENT, LLC | 0.78% | 0.00% | 505,147 | 26,264 | 5.48% | 1,515,818 | Mar 31, 2024 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.56% | 0.00% | 362,600 | 362,600 | 100.00% | 1,087,800 | Mar 31, 2024 |
ACADIAN ASSET MANAGEMENT LLC | 0.51% | 0.00% | 330,526 | -210,650 | -38.92% | 991,000 | Mar 31, 2024 |
BALYASNY ASSET MANAGEMENT L.P. | 0.51% | 0.00% | 329,900 | 329,900 | 100.00% | 989,700 | Mar 31, 2024 |
JANE STREET GROUP, LLC | 0.45% | 0.00% | 289,275 | 232,132 | 406.23% | 867,825 | Mar 31, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | 0.34% | 0.00% | 220,348 | 215,495 | 4440.45% | 661,044 | Mar 31, 2024 |
MARSHALL WACE, LLP | 0.34% | 0.00% | 217,501 | 204,616 | 1588.02% | 652,503 | Mar 31, 2024 |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.28% | 0.00% | 180,787 | 37,428 | 26.11% | 542,361 | Mar 31, 2024 |
STATE STREET CORP | 0.28% | - | 179,265 | -7,500 | -4.02% | 537,795 | Mar 31, 2024 |
IKARIAN CAPITAL, LLC | 0.27% | 0.06% | 172,800 | 172,800 | 100.00% | 518,400 | Mar 31, 2024 |
GlycoMimetics's largest institutional shareholder is BVF INC/IL, holding 14.82% of the company's total share outstanding, currently valued at $28.63M. The top 10 institutional shareholders own together 50.42% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
OCTAGON CAPITAL ADVISORS LP | 4.66% | 1.08% | 3,000,000 | - | - | 9,000,000 | Mar 31, 2024 |
BVF INC/IL | 14.82% | 0.79% | 9,544,262 | - | - | 28,632,786 | Mar 31, 2024 |
NEA MANAGEMENT COMPANY, LLC | 5.96% | 0.71% | 3,835,039 | -929,401 | -19.51% | 11,505,117 | Mar 31, 2024 |
ARTAL GROUP S.A. | 13.34% | 0.66% | 8,589,064 | - | - | 25,767,192 | Mar 31, 2024 |
ADAR1 CAPITAL MANAGEMENT, LLC | 0.22% | 0.09% | 139,100 | 139,100 | 100.00% | 417,300 | Mar 31, 2024 |
SARGENT INVESTMENT GROUP, LLC | 0.17% | 0.07% | 108,000 | 50,000 | 86.21% | 324,000 | Mar 31, 2024 |
IKARIAN CAPITAL, LLC | 0.27% | 0.06% | 172,800 | 172,800 | 100.00% | 518,400 | Mar 31, 2024 |
AFFINITY ASSET ADVISORS, LLC | 0.22% | 0.05% | 142,300 | 142,300 | 100.00% | 426,900 | Mar 31, 2024 |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.08% | 0.04% | 51,868 | 51,868 | 100.00% | 155,604 | Mar 31, 2024 |
INTELLECTUS PARTNERS, LLC | 0.08% | 0.04% | 50,720 | - | - | 152,160 | Mar 31, 2024 |
CTC ALTERNATIVE STRATEGIES, LTD. | 0.03% | 0.03% | 17,700 | 17,700 | 100.00% | 53,100 | Mar 31, 2024 |
AXA S.A. | 2.47% | 0.01% | 1,587,741 | 443 | 0.03% | 4,763,223 | Mar 31, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.26% | 0.01% | 168,600 | -28,600 | -14.50% | 505,800 | Mar 31, 2024 |
TOBIAS FINANCIAL ADVISORS, INC. | 0.02% | 0.01% | 15,000 | - | - | 45,000 | Mar 31, 2024 |
Y-INTERCEPT (HONG KONG) LTD | 0.07% | 0.01% | 43,130 | 16,558 | 62.31% | 129,390 | Mar 31, 2024 |
GSA CAPITAL PARTNERS LLP | 0.03% | 0.00% | 18,321 | -182,672 | -90.88% | 55,000 | Mar 31, 2024 |
ACADIAN ASSET MANAGEMENT LLC | 0.51% | 0.00% | 330,526 | -210,650 | -38.92% | 991,000 | Mar 31, 2024 |
VERITION FUND MANAGEMENT LLC | 0.25% | 0.00% | 162,428 | 162,428 | 100.00% | 487,284 | Mar 31, 2024 |
HRT FINANCIAL LP | 0.24% | 0.00% | 155,830 | 155,830 | 100.00% | 467,000 | Mar 31, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 0.07% | 0.00% | 45,600 | 45,600 | 100.00% | 136,800 | Mar 31, 2024 |
The largest GlycoMimetics shareholder by % of total assets is OCTAGON CAPITAL ADVISORS LP. The company owns 3.00M shares of GlycoMimetics (GLYC), representing 1.08% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MILLENNIUM MANAGEMENT LLC | 1.16% | 0.00% | 746,954 | 708,066 | 1820.78% | 2,240,862 | Mar 31, 2024 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.86% | 0.00% | 554,594 | 554,594 | 100.00% | 1,663,782 | Mar 31, 2024 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.56% | 0.00% | 362,600 | 362,600 | 100.00% | 1,087,800 | Mar 31, 2024 |
VANGUARD GROUP INC | 4.29% | 0.00% | 2,761,981 | 340,112 | 14.04% | 8,285,943 | Mar 31, 2024 |
BALYASNY ASSET MANAGEMENT L.P. | 0.51% | 0.00% | 329,900 | 329,900 | 100.00% | 989,700 | Mar 31, 2024 |
JANE STREET GROUP, LLC | 0.45% | 0.00% | 289,275 | 232,132 | 406.23% | 867,825 | Mar 31, 2024 |
QUBE RESEARCH & TECHNOLOGIES LTD | 0.34% | 0.00% | 220,348 | 215,495 | 4440.45% | 661,044 | Mar 31, 2024 |
MARSHALL WACE, LLP | 0.34% | 0.00% | 217,501 | 204,616 | 1588.02% | 652,503 | Mar 31, 2024 |
GOLDMAN SACHS GROUP INC | 1.73% | 0.00% | 1,114,708 | 195,353 | 21.25% | 3,344,124 | Mar 31, 2024 |
IKARIAN CAPITAL, LLC | 0.27% | 0.06% | 172,800 | 172,800 | 100.00% | 518,400 | Mar 31, 2024 |
VERITION FUND MANAGEMENT LLC | 0.25% | 0.00% | 162,428 | 162,428 | 100.00% | 487,284 | Mar 31, 2024 |
HRT FINANCIAL LP | 0.24% | 0.00% | 155,830 | 155,830 | 100.00% | 467,000 | Mar 31, 2024 |
MAN GROUP PLC | 0.23% | 0.00% | 149,859 | 149,859 | 100.00% | 449,577 | Mar 31, 2024 |
AFFINITY ASSET ADVISORS, LLC | 0.22% | 0.05% | 142,300 | 142,300 | 100.00% | 426,900 | Mar 31, 2024 |
ADAR1 CAPITAL MANAGEMENT, LLC | 0.22% | 0.09% | 139,100 | 139,100 | 100.00% | 417,300 | Mar 31, 2024 |
CITIGROUP INC | 0.21% | 0.00% | 137,667 | 116,139 | 539.48% | 413,001 | Mar 31, 2024 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.18% | 0.00% | 116,100 | 116,100 | 100.00% | 348,300 | Mar 31, 2024 |
JPMORGAN CHASE & CO | 0.13% | - | 84,624 | 83,011 | 5146.37% | 253,872 | Mar 31, 2024 |
MORGAN STANLEY | 0.16% | - | 103,088 | 68,577 | 198.71% | 309,264 | Mar 31, 2024 |
AMERICAN CENTURY COMPANIES INC | 0.10% | 0.00% | 63,642 | 63,642 | 100.00% | 190,926 | Mar 31, 2024 |
As of Mar 31 2024, GlycoMimetics's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 708.07K stocks of GLYC, valued at $2.24M.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
NEA MANAGEMENT COMPANY, LLC | 5.96% | 0.71% | 3,835,039 | -929,401 | -19.51% | 11,505,117 | Mar 31, 2024 |
ACADIAN ASSET MANAGEMENT LLC | 0.51% | 0.00% | 330,526 | -210,650 | -38.92% | 991,000 | Mar 31, 2024 |
GSA CAPITAL PARTNERS LLP | 0.03% | 0.00% | 18,321 | -182,672 | -90.88% | 55,000 | Mar 31, 2024 |
TWO SIGMA ADVISERS, LP | 0.05% | 0.00% | 29,300 | -136,100 | -82.29% | 87,900 | Mar 31, 2024 |
MJP ASSOCIATES INC /ADV | - | - | - | -101,000 | -100.00% | - | Mar 31, 2024 |
ADVISOR OS, LLC | - | - | - | -101,000 | -100.00% | - | Mar 31, 2024 |
FRANKLIN RESOURCES INC | - | - | - | -95,751 | -100.00% | - | Mar 31, 2024 |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.06% | 0.00% | 35,698 | -60,061 | -62.72% | 107,000 | Mar 31, 2024 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -59,621 | -100.00% | - | Mar 31, 2024 |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.26% | 0.01% | 168,600 | -28,600 | -14.50% | 505,800 | Mar 31, 2024 |
BANK OF NEW YORK MELLON CORP | - | - | - | -24,732 | -100.00% | - | Mar 31, 2024 |
683 CAPITAL MANAGEMENT, LLC | - | - | - | -19,384 | -100.00% | - | Mar 31, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -12,464 | -100.00% | - | Mar 31, 2024 |
XTX TOPCO LTD | - | - | - | -11,093 | -100.00% | - | Mar 31, 2024 |
STATE STREET CORP | 0.28% | - | 179,265 | -7,500 | -4.02% | 537,795 | Mar 31, 2024 |
GROUP ONE TRADING, L.P. | 0.04% | 0.00% | 28,679 | -2,574 | -8.24% | 86,037 | Mar 31, 2024 |
BLACKROCK INC. | 1.14% | 0.00% | 732,567 | -2,416 | -0.33% | 2,197,701 | Mar 31, 2024 |
ORG PARTNERS LLC | - | - | - | -500 | -100.00% | - | Mar 31, 2024 |
OCTAGON CAPITAL ADVISORS LP | 4.66% | 1.08% | 3,000,000 | - | - | 9,000,000 | Mar 31, 2024 |
BVF INC/IL | 14.82% | 0.79% | 9,544,262 | - | - | 28,632,786 | Mar 31, 2024 |
As of Mar 31 2024, GlycoMimetics's biggest institutional seller is NEA MANAGEMENT COMPANY, LLC. The company sold -0.93M shares of GLYC, valued at $11.51M.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.86% | 0.00% | 554,594 | 554,594 | 100.00% | 1,663,782 | Mar 31, 2024 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.56% | 0.00% | 362,600 | 362,600 | 100.00% | 1,087,800 | Mar 31, 2024 |
BALYASNY ASSET MANAGEMENT L.P. | 0.51% | 0.00% | 329,900 | 329,900 | 100.00% | 989,700 | Mar 31, 2024 |
IKARIAN CAPITAL, LLC | 0.27% | 0.06% | 172,800 | 172,800 | 100.00% | 518,400 | Mar 31, 2024 |
VERITION FUND MANAGEMENT LLC | 0.25% | 0.00% | 162,428 | 162,428 | 100.00% | 487,284 | Mar 31, 2024 |
HRT FINANCIAL LP | 0.24% | 0.00% | 155,830 | 155,830 | 100.00% | 467,000 | Mar 31, 2024 |
MAN GROUP PLC | 0.23% | 0.00% | 149,859 | 149,859 | 100.00% | 449,577 | Mar 31, 2024 |
AFFINITY ASSET ADVISORS, LLC | 0.22% | 0.05% | 142,300 | 142,300 | 100.00% | 426,900 | Mar 31, 2024 |
ADAR1 CAPITAL MANAGEMENT, LLC | 0.22% | 0.09% | 139,100 | 139,100 | 100.00% | 417,300 | Mar 31, 2024 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.18% | 0.00% | 116,100 | 116,100 | 100.00% | 348,300 | Mar 31, 2024 |
AMERICAN CENTURY COMPANIES INC | 0.10% | 0.00% | 63,642 | 63,642 | 100.00% | 190,926 | Mar 31, 2024 |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.08% | 0.04% | 51,868 | 51,868 | 100.00% | 155,604 | Mar 31, 2024 |
CUBIST SYSTEMATIC STRATEGIES, LLC | 0.08% | 0.00% | 49,798 | 49,798 | 100.00% | 149,394 | Mar 31, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | 0.07% | 0.00% | 45,600 | 45,600 | 100.00% | 136,800 | Mar 31, 2024 |
BALYASNY ASSET MANAGEMENT L.P. | 0.06% | 0.00% | 40,557 | 40,557 | 100.00% | 121,671 | Mar 31, 2024 |
JEFFERIES FINANCIAL GROUP INC. | 0.06% | 0.00% | 38,200 | 38,200 | 100.00% | 114,600 | Mar 31, 2024 |
OMERS ADMINISTRATION CORP | 0.05% | 0.00% | 30,600 | 30,600 | 100.00% | 91,800 | Mar 31, 2024 |
BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.04% | 0.00% | 23,339 | 23,339 | 100.00% | 70,017 | Mar 31, 2024 |
BELVEDERE TRADING LLC | 0.03% | 0.00% | 20,465 | 20,465 | 100.00% | 61,395 | Mar 31, 2024 |
SQUAREPOINT OPS LLC | 0.03% | 0.00% | 20,315 | 20,315 | 100.00% | 60,945 | Mar 31, 2024 |
JUMP FINANCIAL, LLC | 0.03% | 0.00% | 20,103 | 20,103 | 100.00% | 60,309 | Mar 31, 2024 |
SG AMERICAS SECURITIES, LLC | 0.03% | 0.00% | 18,805 | 18,805 | 100.00% | 56,000 | Mar 31, 2024 |
CTC ALTERNATIVE STRATEGIES, LTD. | 0.03% | 0.03% | 17,700 | 17,700 | 100.00% | 53,100 | Mar 31, 2024 |
LMR PARTNERS LLP | 0.02% | 0.00% | 14,102 | 14,102 | 100.00% | 42,306 | Mar 31, 2024 |
BELVEDERE TRADING LLC | 0.01% | - | 3,600 | 3,600 | 100.00% | 10,800 | Mar 31, 2024 |
ROYAL BANK OF CANADA | 0.00% | - | 2,000 | 2,000 | 100.00% | 6,000 | Mar 31, 2024 |
MACQUARIE GROUP LTD | 0.00% | - | 1,939 | 1,939 | 100.00% | 6 | Mar 31, 2024 |
BELVEDERE TRADING LLC | 0.00% | - | 1,400 | 1,400 | 100.00% | 4,200 | Mar 31, 2024 |
OLD POINT TRUST & FINANCIAL SERVICES N A | 0.00% | 0.00% | 500 | 500 | 100.00% | 1,500 | Mar 31, 2024 |
FMR LLC | 0.00% | - | 67 | 67 | 100.00% | 201 | Mar 31, 2024 |
GlycoMimetics's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 554.59K shares, valued at $1.66M, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MJP ASSOCIATES INC /ADV | - | - | - | -101,000 | -100.00% | - | Mar 31, 2024 |
ADVISOR OS, LLC | - | - | - | -101,000 | -100.00% | - | Mar 31, 2024 |
FRANKLIN RESOURCES INC | - | - | - | -95,751 | -100.00% | - | Mar 31, 2024 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -59,621 | -100.00% | - | Mar 31, 2024 |
BANK OF NEW YORK MELLON CORP | - | - | - | -24,732 | -100.00% | - | Mar 31, 2024 |
683 CAPITAL MANAGEMENT, LLC | - | - | - | -19,384 | -100.00% | - | Mar 31, 2024 |
BOOTHBAY FUND MANAGEMENT, LLC | - | - | - | -12,464 | -100.00% | - | Mar 31, 2024 |
XTX TOPCO LTD | - | - | - | -11,093 | -100.00% | - | Mar 31, 2024 |
ORG PARTNERS LLC | - | - | - | -500 | -100.00% | - | Mar 31, 2024 |
GlycoMimetics's largest sold out institutional shareholder by shares sold is MJP ASSOCIATES INC /ADV, sold -0.10M shares, valued at -, as of undefined.
GlycoMimetics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
VANGUARD VALLEY FORGE FUNDS | 0.11% | 54,900 | - | - | Dec 31, 2023 |
Federated Hermes MDT Series | 0.09% | 212,114 | - | - | Jan 31, 2024 |
BRIDGEWAY FUNDS INC | 0.08% | 191,800 | 25,000 | 14.99% | Dec 29, 2023 |
ALGER FUNDS | 0.06% | 55,000 | - | - | Jan 31, 2024 |
BlackRock Advantage SMID Cap Fund, Inc. | 0.05% | 8,547 | - | - | Dec 29, 2023 |
ETFis Series Trust I | 0.04% | 62,689 | - | - | Jan 31, 2024 |
Vericimetry Funds | 0.03% | 3,180 | - | - | Dec 31, 2023 |
AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS) | 0.03% | 975,207 | - | - | Jan 31, 2024 |
FORUM FUNDS II | 0.03% | 24,900 | - | - | Jan 31, 2024 |
FIDELITY COMMONWEALTH TRUST | 0.02% | 78,191 | - | - | Feb 29, 2024 |
DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,874 | - | - | Dec 31, 2023 |
AMG FUNDS III | 0.01% | 1,426 | - | - | Feb 29, 2024 |
QUANTITATIVE MASTER SERIES LLC | 0.01% | 55,407 | - | - | Dec 31, 2023 |
VANGUARD HORIZON FUNDS | 0.01% | 146,428 | - | - | Dec 31, 2023 |
VANGUARD INDEX FUNDS | 0.01% | 2,964,011 | 651,187 | 28.16% | Dec 31, 2023 |
ALPS ETF Trust | 0.01% | 75,579 | - | - | Feb 29, 2024 |
TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,226 | - | - | Dec 31, 2023 |
JNL VARIABLE FUND LLC | 0.01% | 28,975 | - | - | Mar 31, 2020 |
TIAA-CREF LIFE FUNDS | 0.00% | 13,141 | - | - | Dec 31, 2023 |
Fidelity Commonwealth Trust II | 0.00% | 20,861 | - | - | Aug 31, 2023 |
Forethought Variable Insurance Trust | 0.00% | 11,196 | - | - | Dec 29, 2023 |
FIDELITY CONCORD STREET TRUST | 0.00% | 448,400 | 21,094 | 4.94% | Feb 29, 2024 |
Voya PARTNERS INC | 0.00% | 173,554 | - | - | Dec 31, 2023 |
Voya VARIABLE PORTFOLIOS INC | 0.00% | 61,101 | - | - | Dec 31, 2023 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 39,833 | - | - | Dec 31, 2023 |
HARTFORD SERIES FUND INC | 0.00% | 56,862 | - | - | Dec 31, 2023 |
MASSMUTUAL PREMIER FUNDS | 0.00% | 35,564 | - | - | Dec 31, 2023 |
Calvert Variable Products, Inc. | 0.00% | 2,997 | - | - | Dec 31, 2023 |
JOHN HANCOCK INVESTMENT TRUST | 0.00% | 78,363 | - | - | Jan 31, 2024 |
SunAmerica Specialty Series | 0.00% | 306 | - | - | Apr 30, 2021 |
Principal Exchange-Traded Funds | 0.00% | 6,305 | - | - | Mar 31, 2024 |
INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 33,227 | - | - | Jan 31, 2024 |
HC CAPITAL TRUST | 0.00% | 11,674 | - | - | Dec 31, 2023 |
COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 376,069 | - | - | Dec 31, 2023 |
RUSSELL INVESTMENT CO | 0.00% | 84,135 | - | - | Jan 31, 2024 |
NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 34,376 | - | - | Dec 31, 2023 |
VANGUARD QUANTITATIVE FUNDS | 0.00% | 2,100 | - | - | Dec 31, 2023 |
ALLSPRING MASTER TRUST | 0.00% | 15,087 | - | - | Feb 29, 2024 |
LoCorr Investment Trust | 0.00% | 5,507 | - | - | Mar 31, 2024 |
AMERICAN CENTURY ETF TRUST | 0.00% | 19,406 | 16,953 | 691.11% | Feb 29, 2024 |
Meeder Funds | 0.00% | 809 | - | - | Mar 31, 2024 |
VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,857 | - | - | Dec 31, 2023 |
AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 283,790 | - | - | Dec 31, 2023 |
FIDELITY SALEM STREET TRUST | 0.00% | 285,755 | - | - | Feb 29, 2024 |
Legg Mason Global Asset Management Trust | 0.00% | 90,941 | - | - | Jan 31, 2024 |
PGIM ETF TRUST | 0.00% | 6,400 | - | - | Feb 29, 2024 |
ProFunds | 0.00% | 804 | - | - | Jan 31, 2024 |
PACE SELECT ADVISORS TRUST | 0.00% | 26,108 | - | - | Jan 31, 2024 |
STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 6,791 | - | - | Dec 31, 2023 |
MASTER INVESTMENT PORTFOLIO | 0.00% | 5,325 | - | - | Dec 31, 2023 |
VALIC Co I | 0.00% | 17,588 | - | - | Feb 29, 2024 |
VANGUARD SCOTTSDALE FUNDS | 0.00% | 110,887 | - | - | Feb 29, 2024 |
HARTFORD MUTUAL FUNDS INC/CT | 0.00% | 404,265 | - | - | Jan 31, 2024 |
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 2,517 | - | - | Dec 31, 2023 |
PENN SERIES FUNDS INC | 0.00% | 1,300 | - | - | Dec 29, 2023 |
FINANCIAL INVESTORS TRUST | 0.00% | 2,843 | - | - | Jan 31, 2024 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 4,290 | -1,078 | -20.08% | Jan 31, 2024 |
Blackstone Alternative Investment Funds | 0.00% | 2,900 | -300 | -9.38% | Dec 31, 2023 |
Dimensional ETF Trust | 0.00% | 8,890 | - | - | Jan 31, 2024 |
T. Rowe Price Index Trust, Inc. | 0.00% | 331 | - | - | Feb 29, 2024 |
MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,545 | - | - | Feb 29, 2024 |
VANGUARD WELLINGTON FUND | 0.00% | 5,974 | - | - | Feb 29, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 4,952 | - | - | Jan 31, 2024 |
Brighthouse Funds Trust II | 0.00% | 28,848 | - | - | Dec 31, 2023 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 12,930 | - | - | Jan 31, 2024 |
NORTHERN FUNDS | 0.00% | 11,161 | - | - | Dec 29, 2023 |
iShares U.S. ETF Trust | 0.00% | 1,013 | - | - | Jan 31, 2024 |
Brighthouse Funds Trust I | 0.00% | 91,804 | - | - | Dec 31, 2023 |
EQ ADVISORS TRUST | 0.00% | 8,767 | -1,298 | -12.90% | Dec 31, 2023 |
iSHARES TRUST | 0.00% | 118,446 | - | - | Feb 29, 2024 |
PACIFIC SELECT FUND | 0.00% | 22,684 | - | - | Dec 31, 2023 |
MASSMUTUAL SELECT FUNDS | 0.00% | 4,792 | - | - | Dec 31, 2023 |
Bridge Builder Trust | 0.00% | 13,520 | - | - | Dec 31, 2023 |
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 3,789 | - | - | Dec 31, 2023 |
Advisors' Inner Circle Fund III | 0.00% | 22 | - | - | Jan 31, 2024 |
BlackRock Variable Series Funds, Inc. | 0.00% | 4,523 | - | - | Dec 31, 2023 |
PRINCIPAL FUNDS, INC. | 0.00% | 4,317 | - | - | Feb 29, 2024 |
BLACKROCK FUNDS | 0.00% | 3,909 | - | - | Feb 29, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 933 | - | - | Dec 31, 2023 |
John Hancock Funds II | 0.00% | 6,083 | - | - | Feb 29, 2024 |
SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 6,500 | - | - | Feb 29, 2024 |
VANGUARD WORLD FUND | 0.00% | 60 | - | - | Feb 29, 2024 |
GlycoMimetics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 54.90K shares, compromising 0.11% of its total assets.
GlycoMimetics Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 24 | 81 | 39.66% |
31 Dec, 23 | 58 | 23.40% |
30 Sep, 23 | 47 | -11.32% |
30 Jun, 23 | 53 | -13.11% |
31 Mar, 23 | 61 | 27.08% |
31 Dec, 22 | 48 | 65.52% |
30 Sep, 22 | 29 | -3.33% |
30 Jun, 22 | 30 | -21.05% |
31 Mar, 22 | 38 | -17.39% |
31 Dec, 21 | 46 | -2.13% |
30 Sep, 21 | 47 | -18.97% |
30 Jun, 21 | 58 | -22.67% |
31 Mar, 21 | 75 | -16.67% |
31 Dec, 20 | 90 | 12.50% |
30 Sep, 20 | 80 | -4.76% |
30 Jun, 20 | 84 | 13.51% |
31 Mar, 20 | 74 | -7.50% |
31 Dec, 19 | 80 | 6.67% |
30 Sep, 19 | 75 | -3.85% |
30 Jun, 19 | 78 | -1.27% |
31 Mar, 19 | 79 | -2.47% |
31 Dec, 18 | 81 | -8.99% |
30 Sep, 18 | 89 | 1.14% |
30 Jun, 18 | 88 | - |
31 Mar, 18 | 88 | 11.39% |
31 Dec, 17 | 79 | 38.60% |
30 Sep, 17 | 57 | -17.39% |
30 Jun, 17 | 69 | 60.47% |
31 Mar, 17 | 43 | -14.00% |
31 Dec, 16 | 50 | 4.17% |
30 Sep, 16 | 48 | -5.88% |
30 Jun, 16 | 51 | 75.86% |
31 Mar, 16 | 29 | 3.57% |
31 Dec, 15 | 28 | -6.67% |
30 Sep, 15 | 30 | -3.23% |
30 Jun, 15 | 31 | 10.71% |
31 Mar, 15 | 28 | - |
31 Dec, 14 | 28 | 3.70% |
30 Sep, 14 | 27 | -12.90% |
30 Jun, 14 | 31 | -13.89% |
31 Mar, 14 | 36 | - |
As of 31 Mar 24, 81 institutions are holding GlycoMimetics's shares, representing an increase of 39.66% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 24 | 36,848,906 | 5.31% |
31 Dec, 23 | 34,990,173 | 0.79% |
30 Sep, 23 | 34,716,628 | -2.32% |
30 Jun, 23 | 35,539,400 | -3.69% |
31 Mar, 23 | 36,902,187 | 34.88% |
31 Dec, 22 | 27,358,861 | 5.49% |
30 Sep, 22 | 25,934,578 | -1.88% |
30 Jun, 22 | 26,432,157 | -3.04% |
31 Mar, 22 | 27,260,030 | -7.03% |
31 Dec, 21 | 29,320,067 | -0.36% |
30 Sep, 21 | 29,426,427 | -5.21% |
30 Jun, 21 | 31,044,021 | -15.09% |
31 Mar, 21 | 36,560,722 | -5.25% |
31 Dec, 20 | 38,585,931 | -3.12% |
30 Sep, 20 | 39,827,729 | -1.26% |
30 Jun, 20 | 40,335,886 | 1.76% |
31 Mar, 20 | 39,637,462 | -4.61% |
31 Dec, 19 | 41,553,079 | -0.13% |
30 Sep, 19 | 41,605,901 | -7.15% |
30 Jun, 19 | 44,808,447 | -1.41% |
31 Mar, 19 | 45,450,304 | 0.54% |
31 Dec, 18 | 45,207,377 | -2.52% |
30 Sep, 18 | 46,377,138 | 0.10% |
30 Jun, 18 | 46,332,384 | 6.09% |
31 Mar, 18 | 43,672,246 | 37.80% |
31 Dec, 17 | 31,692,369 | 6.94% |
30 Sep, 17 | 29,634,328 | -1.92% |
30 Jun, 17 | 30,214,931 | 57.97% |
31 Mar, 17 | 19,126,550 | 1.02% |
31 Dec, 16 | 18,933,759 | 2.87% |
30 Sep, 16 | 18,406,240 | -0.53% |
30 Jun, 16 | 18,503,810 | 31.61% |
31 Mar, 16 | 14,059,054 | 1.38% |
31 Dec, 15 | 13,867,664 | -23.31% |
30 Sep, 15 | 18,082,570 | 31.35% |
30 Jun, 15 | 13,767,009 | 0.16% |
31 Mar, 15 | 13,745,019 | -1.10% |
31 Dec, 14 | 13,897,578 | 3.73% |
30 Sep, 14 | 13,398,153 | -0.88% |
30 Jun, 14 | 13,517,067 | -3.93% |
31 Mar, 14 | 14,070,230 | - |
GlycoMimetics (GLYC) has 36.85M shares outstanding as of 31 Mar 24, up 5.31% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 24 | 57.22% | 1.94% |
31 Dec, 23 | 54.38% | 1.86% |
30 Sep, 23 | 54.01% | 1.56% |
30 Jun, 23 | 58.89% | 1.58% |
31 Mar, 23 | 61.15% | 2.29% |
31 Dec, 22 | 51.66% | 2.11% |
30 Sep, 22 | 49.47% | 1.94% |
30 Jun, 22 | 50.44% | 1.86% |
31 Mar, 22 | 52.09% | 1.60% |
31 Dec, 21 | 56.98% | 1.75% |
30 Sep, 21 | 57.07% | 1.57% |
30 Jun, 21 | 60.23% | 1.16% |
31 Mar, 21 | 72.12% | 1.01% |
31 Dec, 20 | 84.39% | 1.20% |
30 Sep, 20 | 83.83% | 0.99% |
30 Jun, 20 | 92.09% | 1.11% |
31 Mar, 20 | 90.96% | 0.99% |
31 Dec, 19 | 96.07% | 1.04% |
30 Sep, 19 | 96.10% | 0.89% |
30 Jun, 19 | 103.76% | 0.94% |
31 Mar, 19 | 105.29% | 0.96% |
31 Dec, 18 | 104.78% | 0.90% |
30 Sep, 18 | 107.68% | 0.92% |
30 Jun, 18 | 108.23% | 0.70% |
31 Mar, 18 | 124.22% | 1.53% |
31 Dec, 17 | 90.15% | 1.10% |
30 Sep, 17 | 90.56% | 0.74% |
30 Jun, 17 | 110.92% | 1.67% |
31 Mar, 17 | 81.46% | 1.21% |
31 Dec, 16 | 81.93% | 1.28% |
30 Sep, 16 | 79.86% | 0.91% |
30 Jun, 16 | 93.49% | 1.72% |
31 Mar, 16 | 73.72% | 1.39% |
31 Dec, 15 | 72.82% | 0.81% |
30 Sep, 15 | 95.04% | 1.81% |
30 Jun, 15 | 72.41% | 1.38% |
31 Mar, 15 | 72.49% | 1.34% |
31 Dec, 14 | 73.52% | 1.46% |
30 Sep, 14 | 70.91% | 1.37% |
30 Jun, 14 | 71.87% | 1.08% |
31 Mar, 14 | 81.65% | - |
As of 31 Mar 24, GlycoMimetics is held by 57.22% institutional shareholders, representing a 1.94% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 24 | 49 | 81.48% |
31 Dec, 23 | 27 | 125.00% |
30 Sep, 23 | 12 | -7.69% |
30 Jun, 23 | 13 | -62.86% |
31 Mar, 23 | 35 | 34.62% |
31 Dec, 22 | 26 | 225.00% |
30 Sep, 22 | 8 | 14.29% |
30 Jun, 22 | 7 | -36.36% |
31 Mar, 22 | 11 | -45.00% |
31 Dec, 21 | 20 | 42.86% |
30 Sep, 21 | 14 | -39.13% |
30 Jun, 21 | 23 | -28.13% |
31 Mar, 21 | 32 | -38.46% |
31 Dec, 20 | 52 | 85.71% |
30 Sep, 20 | 28 | -47.17% |
30 Jun, 20 | 53 | 39.47% |
31 Mar, 20 | 38 | -7.32% |
31 Dec, 19 | 41 | 2.50% |
30 Sep, 19 | 40 | 17.65% |
30 Jun, 19 | 34 | -17.07% |
31 Mar, 19 | 41 | 10.81% |
31 Dec, 18 | 37 | -13.95% |
30 Sep, 18 | 43 | -20.37% |
30 Jun, 18 | 54 | -10.00% |
31 Mar, 18 | 60 | 13.21% |
31 Dec, 17 | 53 | 70.97% |
30 Sep, 17 | 31 | -42.59% |
30 Jun, 17 | 54 | 237.50% |
31 Mar, 17 | 16 | -40.74% |
31 Dec, 16 | 27 | 28.57% |
30 Sep, 16 | 21 | -46.15% |
30 Jun, 16 | 39 | 254.55% |
31 Mar, 16 | 11 | -21.43% |
31 Dec, 15 | 14 | 16.67% |
30 Sep, 15 | 12 | -33.33% |
30 Jun, 15 | 18 | 12.50% |
31 Mar, 15 | 16 | 23.08% |
31 Dec, 14 | 13 | 30.00% |
30 Sep, 14 | 10 | -44.44% |
30 Jun, 14 | 18 | -50.00% |
31 Mar, 14 | 36 | - |
49 institutional shareholders have increased their position in GLYC stock as of 31 Mar 24 compared to 27 in the previous quarter (a 81.48% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 24 | 9 | -30.77% |
31 Dec, 23 | 13 | -27.78% |
30 Sep, 23 | 18 | -5.26% |
30 Jun, 23 | 19 | 90.00% |
31 Mar, 23 | 10 | -23.08% |
31 Dec, 22 | 13 | 116.67% |
30 Sep, 22 | 6 | -50.00% |
30 Jun, 22 | 12 | -29.41% |
31 Mar, 22 | 17 | 30.77% |
31 Dec, 21 | 13 | -35.00% |
30 Sep, 21 | 20 | -9.09% |
30 Jun, 21 | 22 | -4.35% |
31 Mar, 21 | 23 | 21.05% |
31 Dec, 20 | 19 | -40.63% |
30 Sep, 20 | 32 | 45.45% |
30 Jun, 20 | 22 | -12.00% |
31 Mar, 20 | 25 | -3.85% |
31 Dec, 19 | 26 | 36.84% |
30 Sep, 19 | 19 | -38.71% |
30 Jun, 19 | 31 | 40.91% |
31 Mar, 19 | 22 | -15.38% |
31 Dec, 18 | 26 | 8.33% |
30 Sep, 18 | 24 | 9.09% |
30 Jun, 18 | 22 | 29.41% |
31 Mar, 18 | 17 | -15.00% |
31 Dec, 17 | 20 | 33.33% |
30 Sep, 17 | 15 | 36.36% |
30 Jun, 17 | 11 | -8.33% |
31 Mar, 17 | 12 | 50.00% |
31 Dec, 16 | 8 | -46.67% |
30 Sep, 16 | 15 | 200.00% |
30 Jun, 16 | 5 | -37.50% |
31 Mar, 16 | 8 | 60.00% |
31 Dec, 15 | 5 | -50.00% |
30 Sep, 15 | 10 | 150.00% |
30 Jun, 15 | 4 | - |
31 Mar, 15 | 4 | -33.33% |
31 Dec, 14 | 6 | -40.00% |
30 Sep, 14 | 10 | 11.11% |
30 Jun, 14 | 9 | - |
31 Mar, 14 | - | - |
9 institutional shareholders have reduced their position in GLYC stock as of 31 Mar 24 compared to 13 in the previous quarter (a -30.77% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 24 | 81 | 39.66% | 36,848,906 | 5.31% | 57.22% | 1.94% | 49 | 81.48% | 9 | -30.77% |
31 Dec, 23 | 58 | 23.40% | 34,990,173 | 0.79% | 54.38% | 1.86% | 27 | 125.00% | 13 | -27.78% |
30 Sep, 23 | 47 | -11.32% | 34,716,628 | -2.32% | 54.01% | 1.56% | 12 | -7.69% | 18 | -5.26% |
30 Jun, 23 | 53 | -13.11% | 35,539,400 | -3.69% | 58.89% | 1.58% | 13 | -62.86% | 19 | 90.00% |
31 Mar, 23 | 61 | 27.08% | 36,902,187 | 34.88% | 61.15% | 2.29% | 35 | 34.62% | 10 | -23.08% |
31 Dec, 22 | 48 | 65.52% | 27,358,861 | 5.49% | 51.66% | 2.11% | 26 | 225.00% | 13 | 116.67% |
30 Sep, 22 | 29 | -3.33% | 25,934,578 | -1.88% | 49.47% | 1.94% | 8 | 14.29% | 6 | -50.00% |
30 Jun, 22 | 30 | -21.05% | 26,432,157 | -3.04% | 50.44% | 1.86% | 7 | -36.36% | 12 | -29.41% |
31 Mar, 22 | 38 | -17.39% | 27,260,030 | -7.03% | 52.09% | 1.60% | 11 | -45.00% | 17 | 30.77% |
31 Dec, 21 | 46 | -2.13% | 29,320,067 | -0.36% | 56.98% | 1.75% | 20 | 42.86% | 13 | -35.00% |
30 Sep, 21 | 47 | -18.97% | 29,426,427 | -5.21% | 57.07% | 1.57% | 14 | -39.13% | 20 | -9.09% |
30 Jun, 21 | 58 | -22.67% | 31,044,021 | -15.09% | 60.23% | 1.16% | 23 | -28.13% | 22 | -4.35% |
31 Mar, 21 | 75 | -16.67% | 36,560,722 | -5.25% | 72.12% | 1.01% | 32 | -38.46% | 23 | 21.05% |
31 Dec, 20 | 90 | 12.50% | 38,585,931 | -3.12% | 84.39% | 1.20% | 52 | 85.71% | 19 | -40.63% |
30 Sep, 20 | 80 | -4.76% | 39,827,729 | -1.26% | 83.83% | 0.99% | 28 | -47.17% | 32 | 45.45% |
30 Jun, 20 | 84 | 13.51% | 40,335,886 | 1.76% | 92.09% | 1.11% | 53 | 39.47% | 22 | -12.00% |
31 Mar, 20 | 74 | -7.50% | 39,637,462 | -4.61% | 90.96% | 0.99% | 38 | -7.32% | 25 | -3.85% |
31 Dec, 19 | 80 | 6.67% | 41,553,079 | -0.13% | 96.07% | 1.04% | 41 | 2.50% | 26 | 36.84% |
30 Sep, 19 | 75 | -3.85% | 41,605,901 | -7.15% | 96.10% | 0.89% | 40 | 17.65% | 19 | -38.71% |
30 Jun, 19 | 78 | -1.27% | 44,808,447 | -1.41% | 103.76% | 0.94% | 34 | -17.07% | 31 | 40.91% |
31 Mar, 19 | 79 | -2.47% | 45,450,304 | 0.54% | 105.29% | 0.96% | 41 | 10.81% | 22 | -15.38% |
31 Dec, 18 | 81 | -8.99% | 45,207,377 | -2.52% | 104.78% | 0.90% | 37 | -13.95% | 26 | 8.33% |
30 Sep, 18 | 89 | 1.14% | 46,377,138 | 0.10% | 107.68% | 0.92% | 43 | -20.37% | 24 | 9.09% |
30 Jun, 18 | 88 | - | 46,332,384 | 6.09% | 108.23% | 0.70% | 54 | -10.00% | 22 | 29.41% |
31 Mar, 18 | 88 | 11.39% | 43,672,246 | 37.80% | 124.22% | 1.53% | 60 | 13.21% | 17 | -15.00% |
31 Dec, 17 | 79 | 38.60% | 31,692,369 | 6.94% | 90.15% | 1.10% | 53 | 70.97% | 20 | 33.33% |
30 Sep, 17 | 57 | -17.39% | 29,634,328 | -1.92% | 90.56% | 0.74% | 31 | -42.59% | 15 | 36.36% |
30 Jun, 17 | 69 | 60.47% | 30,214,931 | 57.97% | 110.92% | 1.67% | 54 | 237.50% | 11 | -8.33% |
31 Mar, 17 | 43 | -14.00% | 19,126,550 | 1.02% | 81.46% | 1.21% | 16 | -40.74% | 12 | 50.00% |
31 Dec, 16 | 50 | 4.17% | 18,933,759 | 2.87% | 81.93% | 1.28% | 27 | 28.57% | 8 | -46.67% |
30 Sep, 16 | 48 | -5.88% | 18,406,240 | -0.53% | 79.86% | 0.91% | 21 | -46.15% | 15 | 200.00% |
30 Jun, 16 | 51 | 75.86% | 18,503,810 | 31.61% | 93.49% | 1.72% | 39 | 254.55% | 5 | -37.50% |
31 Mar, 16 | 29 | 3.57% | 14,059,054 | 1.38% | 73.72% | 1.39% | 11 | -21.43% | 8 | 60.00% |
31 Dec, 15 | 28 | -6.67% | 13,867,664 | -23.31% | 72.82% | 0.81% | 14 | 16.67% | 5 | -50.00% |
30 Sep, 15 | 30 | -3.23% | 18,082,570 | 31.35% | 95.04% | 1.81% | 12 | -33.33% | 10 | 150.00% |
30 Jun, 15 | 31 | 10.71% | 13,767,009 | 0.16% | 72.41% | 1.38% | 18 | 12.50% | 4 | - |
31 Mar, 15 | 28 | - | 13,745,019 | -1.10% | 72.49% | 1.34% | 16 | 23.08% | 4 | -33.33% |
31 Dec, 14 | 28 | 3.70% | 13,897,578 | 3.73% | 73.52% | 1.46% | 13 | 30.00% | 6 | -40.00% |
30 Sep, 14 | 27 | -12.90% | 13,398,153 | -0.88% | 70.91% | 1.37% | 10 | -44.44% | 10 | 11.11% |
30 Jun, 14 | 31 | -13.89% | 13,517,067 | -3.93% | 71.87% | 1.08% | 18 | -50.00% | 9 | - |
31 Mar, 14 | 36 | - | 14,070,230 | - | 81.65% | - | 36 | - | - | - |
GlycoMimetics Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
All Insider Owners Trades
GlycoMimetics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | 7 | - | - |
Q1 2024 | 8 | - | - |
Q4 2023 | 3 | - | - |
Q3 2023 | 5 | - | - |
Q2 2023 | 10 | 2 | 500.00% |
Q1 2023 | 12 | 17 | 70.59% |
Q4 2022 | 9 | 2 | 450.00% |
Q3 2022 | 1 | 1 | 100.00% |
Q2 2022 | 13 | - | - |
Q1 2022 | 7 | 3 | 233.33% |
Q4 2021 | 1 | - | - |
Q3 2021 | - | 2 | - |
Q2 2021 | 12 | - | - |
Q1 2021 | 10 | 5 | 200.00% |
Q4 2020 | 8 | 3 | 266.67% |
Q2 2020 | 6 | - | - |
Q1 2020 | 7 | 1 | 700.00% |
Q4 2019 | 1 | 1 | 100.00% |
Q3 2019 | 5 | 4 | 125.00% |
Q2 2019 | 6 | - | - |
7 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by GlycoMimetics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | - | - | - |
Q1 2024 | - | - | - |
Q4 2023 | - | - | - |
Q3 2023 | 2 | - | - |
Q2 2023 | 2 | 1 | 200.00% |
Q1 2023 | 8 | 10 | 80.00% |
Q4 2022 | 9 | 2 | 450.00% |
Q3 2022 | - | - | - |
Q2 2022 | - | - | - |
Q1 2022 | - | 3 | - |
Q4 2021 | 1 | - | - |
Q3 2021 | - | - | - |
Q2 2021 | - | - | - |
Q1 2021 | - | - | - |
Q4 2020 | 6 | 1 | 600.00% |
Q2 2020 | - | - | - |
Q1 2020 | 1 | - | - |
Q4 2019 | - | - | - |
Q3 2019 | 4 | - | - |
Q2 2019 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of GlycoMimetics's stocks.
GlycoMimetics Peer Ownership
Ticker | Company |
---|---|
ANTX | AN2 Therapeutics, Inc. |
MLYS | Mineralys Therapeutics, Inc. |
SPRO | Spero Therapeutics, Inc. |
FHTX | Foghorn Therapeutics Inc. |
TIL | Instil Bio, Inc. |
IVA | Inventiva S.A. |
DYN | Dyne Therapeutics, Inc. |
CUE | Cue Biopharma, Inc. |
BCAB | BioAtla, Inc. |
ACHL | Achilles Therapeutics plc |
TRVI | Trevi Therapeutics, Inc. |
NLTX | Neurogene Inc. |
ASMB | Assembly Biosciences, Inc. |
LIFE | aTyr Pharma, Inc. |
GLYC Ownership FAQ
Who Owns GlycoMimetics?
GlycoMimetics is owned by institutional shareholders (57.22%), insiders (3.58%), and public (39.20%). The largest institutional shareholder of GlycoMimetics is BVF INC/IL (14.82% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.11% of total shares).
Who are the major institutional shareholders of GlycoMimetics?
GlycoMimetics's major institutional shareholders are BVF INC/IL, ARTAL GROUP S.A., NEA MANAGEMENT COMPANY, LLC, OCTAGON CAPITAL ADVISORS LP, and VANGUARD GROUP INC. The top five shareholders own together 43.06% of the company's share outstanding.
How many GlycoMimetics shareholders are there?
As of Mar 2024, there are 81 institutional shareholders of GlycoMimetics.
What percentage of GlycoMimetics is owned by BVF INC/IL?
BVF INC/IL owns 9.54M shares of GlycoMimetics, representing 14.82% of the company's total shares outstanding, valued at $28.63M (as of Mar 2024).
What percentage of GlycoMimetics is owned by ARTAL GROUP S.A?
As of Mar 2024, ARTAL GROUP S.A holds 8.59M shares of GlycoMimetics (GLYC), compromising 13.34% of the company, valued at $25.77M.
What percentage of GlycoMimetics is owned by NEA MANAGEMENT COMPANY, LLC?
NEA MANAGEMENT COMPANY, LLC is the third largest holder of GlycoMimetics. The company owns 3.84M of the company's shares outstanding (worth $11.51M).